Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.
about
α1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms.Efficacy and Safety of the Selective α1A-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in KoreaSilodosin: a review of its use in the treatment of the signs and symptoms of benign prostatic hyperplasia.A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia.Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study).Silodosin in the treatment of distal ureteric stones in children: A prospective, randomised, placebo-controlled studyPersonalized therapeutics of α₁-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.Effects of silodosin on sexual function - realistic picture from the everyday clinical practice.Efficacy and safety of PDE5-Is and α-1 blockers for treating lower ureteric stones or LUTS: a meta-analysis of RCTs.
P2860
Q28070342-F9632D0E-3DFF-42D6-A86F-02DC69240C61Q30249162-65E9E0B4-2B10-4604-B860-802B93FC908DQ33633716-A50FBE81-56A9-43D7-A5A0-9392D63435C8Q38313282-41838E20-2110-4E4C-BF7F-5FE7E3C78F8DQ38485721-E425E689-A160-4140-AC3C-6B615732EC76Q38845916-28BE6C16-B4A2-449D-B499-C07A32C9B24BQ39926524-D4231CD0-5F2B-4D39-9F36-C97CA7D8E2F4Q42652338-0B26F27A-B1E8-41C2-99C3-5C7E8432D086Q42653540-D092F590-5191-4866-92D3-8C69EFD82092Q45422268-6822D2E2-7685-48A5-9B79-DEDE65F1590BQ48935484-992C1AEC-C898-48E2-92F3-B9F0FBF6E9F8Q54915756-C22627C7-BD33-49E1-985D-B0B22DA6E421
P2860
Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Silodosin in the management of ...... : who are the best candidates.
@en
type
label
Silodosin in the management of ...... : who are the best candidates.
@en
prefLabel
Silodosin in the management of ...... : who are the best candidates.
@en
P2093
P2860
P356
P1476
Silodosin in the management of ...... : who are the best candidates.
@en
P2093
A Briganti
F Montorsi
U Capitanio
P2860
P304
P356
10.1111/IJCP.12135
P577
2013-02-15T00:00:00Z